TLC599
-
Coming to America: Malvern’s Endo Agrees to Bring Taiwanese Pharma Firm’s Drug Candidate to the U.S.
Endo Ventures, a subsidiary of Malvern-based Endo, has reached an agreement with Taiwan Liposome to commercialize its experimental osteoarthritis knee pain drug in the United…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
